Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

Overview
Date Founded

2008

Headquarters

2155 Park Boulevard, Palo Alto, CA, 94306, USA

Type of Company

Public

Employees (Worldwide)

28

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.

Contact Data
Trying to get in touch with decision makers at Eiger BioPharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Director, President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Executive Vice President & Chief Commercial Officer

Chief Business Officer

Director, Chemistry

Senior Vice President, Progeria Program

Senior Vice President, Clinical & Development Operations

Senior Vice President, Progeria Program Lead

Vice President-Medical Affairs

Board of Directors

Chairman & Chief Executive Officer at Waypoint Holdings LLC

Executive Vice President & General Manager, North America at Jazz Pharmaceuticals, Inc.

Executive Vice President & Chief Patient Officer at Vertex Pharmaceuticals, Inc.

Chief Executive Officer & Director at BlueSphere Bio, Inc.

Chief Executive Officer at Paratek Pharmaceuticals Inc.

Senior Vice President & Head of Global Regulatory Affairs at Ultragenyx Pharmaceutical, Inc.

Director, President & Chief Executive Officer at Eiger BioPharmaceuticals, Inc.

Associate Professor & Director-Hepatitis Center at Stanford University - School of Medicine

Paths to Eiger BioPharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Eiger BioPharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

683CM’s research process includes reviewing financial documents for a particular company and often related companies, financial modeling, review of legal documents, contact with company managements and other business people.

Details Hidden

Knoll Capital Management manages a long/short US equity fund that invests primarily in the stocks of small-cap companies in the health technology sector. The firm employs a fundamental, bottom-up individual stock selection process. They employ a fundamental short selling strategy. Knoll Capital Management's investment approach is based on disciplined risk management with sector/position limits, price targets and stop losses. The firm does not use arbitrage, futures or pairs trading. Their use of puts and calls is limited

Details Hidden

InterWest Partners focuses on early-stage investments in life sciences and information technology companies. Within the life sciences sector, the firm invests in a range of early-stage opportunities including the funding of preclinical companies with great potential. They also consider investing in or starting new companies around clinical or commercial stage assets. Within the information technology sector, InterWest looks for early-stage companies with near-term ROI-based value propositions. They favor investments in development-stage companies. Investments average $10 million to $15 million over the life of a company. InterWest serves as the lead investor in the majority of their investments.

Recent Transactions
Details Hidden

Eiger BioPharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Eiger BioPharmaceuticals, Inc. issued . USD Common Stock

Details Hidden

Eiger BioPharmaceuticals, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onEiger BioPharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onEiger BioPharmaceuticals, Inc. issued USD Common Stock

Auditor

Advised onEiger BioPharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onEiger BioPharmaceuticals, Inc. issued . USD Common Stock

Managing Director

Advised onEiger BioPharmaceuticals, Inc. issued USD Common Stock

Associate

Advised onEiger BioPharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants
Scientific Advisor

Chief of Consultative Cardiology at Stanford University - School of Medicine

Scientific Advisor

Associate Professor & Director-Hepatitis Center at Stanford University - School of Medicine

Scientific Advisor

Associate Professor of Medicine Chief of Pulmonary & Critical Care Medicine at Stanford University - School of Medicine

Clients

Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Key Stats and Financials As of 2020
Market Capitalization
$288M
Total Enterprise Value
$250M
Earnings Per Share
$-2.31
Net Profit
$-65M
EBITDA
$-61.5M
Total Debt
$32.5M
Total Equity
$95M
TEVNet Income
-3.84x
Debt TEV
0.13x
Revenue
$0
Suppliers
Bristol-Myers Squibb Company Medical Support Services | New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Stanford University Biotechnology | Stanford, CA

Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. Stanford was founded in 1885 by Leland and Jane Stanford in memory of their only child, Leland Stanford Jr., who had died of typhoid fever at age 15 the previous year. Stanford is generally ranked among the best universities in the world by academic publications. It is also one of the top fundraising institutions in the country, becoming the first school to raise more than a billion dollars in a year.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eiger BioPharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eiger BioPharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Eiger BioPharmaceuticals, Inc..